Therapeutics

Top Story

Researchers says tacrolimus may be first-line treatment for patients with VKC

April 29, 2016

Low-dose topical tacrolimus 0.01% solution showed long-term, positive results as a steroid-sparing agent in the management of refractory vernal keratoconjunctivitis, according to researchers in Clinical Ophthalmology.

A total of 62 consecutive patients with bilateral VKC, unaffected by conventional topical treatments were included in the retrospective review.

BLOG: Why do they call it Muro 128?

April 28, 2016
“Why do they call it Muro-128?” This one stumped me. As I’ve mentioned before, I write this column each month based on a question. Sometimes it’s…
Meeting News Coverage

Expert panel shares pearls on punctal occlusion

April 25, 2016
NEW YORK – A trio of clinicians recommended the use of punctal occlusion, with specific caveats depending on preoperative use and the type of ocular surface…
Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with maximal-tolerable medical therapy, according to a…
Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with…
More »
Meeting News Coverage

Proactive approach to OSD improves surgical outcomes, contact lens success

April 22, 2016
NEW YORK – Do not wait for a patient to say he or she has dry eye; assess his or her risk and symptoms and…
More »
Featured
Vision Expo East

Vision Expo East

Perspectives on Glaucoma

Glaucoma patients found to have greater risk of unsafe driving

April 26, 2016
Glaucoma patients at the greatest risk for unsafe driving exhibited slower performance on psychometric and mobility…
More »
In the Journals

Researchers says tacrolimus may be first-line treatment for patients with VKC

April 29, 2016
Low-dose topical tacrolimus 0.01% solution showed long-term, positive results as a steroid-sparing agent in the management of refractory vernal…

BLOG: Why do they call it Muro 128?

April 28, 2016
“Why do they call it Muro-128?” This one stumped me. As I’ve mentioned before, I write this column each month based on a question…
Meeting News Coverage

Expert panel shares pearls on punctal occlusion

April 25, 2016
NEW YORK – A trio of clinicians recommended the use of punctal occlusion, with specific caveats depending on preoperative use and the type of…
Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with maximal-tolerable medical…
Perspectives on Glaucoma

Higher glaucoma medication confidence when providers educate patients

April 21, 2016
Researchers found higher patient confidence in adhering to glaucoma medication regimens and confidence to administer eye drops correctly when…
Perspectives on Glaucoma

Prostaglandins offer greater short-term IOP reduction than other classes

April 20, 2016
Bimatoprost, latanoprost and travoprost offered the best results at 3 months for primary open-angle glaucoma in a meta-analysis of 114 randomized…

Senate committee recommends PATH Act for superbug treatment

April 6, 2016
A bill aimed at shortening the development time for superbug treatments was recommended today by the U.S. Senate Committee on Health, Education…
In the Journals

Ocular surface concerns due to glaucoma agents may be overestimated

April 5, 2016
Ocular surface changes caused by antiglaucoma medications in stable, medically treated, compliant patients with no dry eye history are mostly…

AOA announces 2016 hall of fame inductees

April 4, 2016
The American Optometric Association and Optometry Cares—The AOA Foundation congratulate three AOA member doctors of optometry selected for…
In the Journals

IOP-reducing effect of hormone therapy likely driven by estrogen

April 1, 2016
Postmenopausal women with a hysterectomy who received estrogen-alone treatment had a significantly lower IOP than women who received placebo 5 years…
More Headlines »
morganatic-roan